We're no longer in the heyday of HIIT (high-intensity interval training) and CrossFit. Now, low-impact and functional fitness workouts are all the rage for American adults.
Why it matters: As longevity becomes a primary health focus, more adults are prioritizing workouts that help them in the long-term by being easier on the body and improving strength and flexibility.
Why it matters: The unique approval further expands the market for the blockbuster drug, part of a class of GLP-1 medications that have seen explosive growth as treatments for diabetes and obesity despite their high list prices.
Novo Nordisk shares, already soaring on the popularity of Ozempic and Wegovy, notched a record high Thursday after reporting positive early results for another weight-loss drug candidate.
The big picture: The drug giant's stock has increased more than 88% in price over the past year, and closed trading Thursday as the 12th largest company in the world by market value, surpassing Tesla.
The Food and Drug Administration is asking outside advisers to review the safety and efficacy of an experimental Alzheimer's drug from Eli Lilly that was expected to be approved in the first quarter of this year.
Why it matters: Donanemab was shown to be effective in slowing the disease's progression by about a third, and would be the second drug of its kind to receive full FDA approval and corresponding Medicare coverage.
Health care is uniquely vulnerable to worker shortages as the U.S. population ages over the next decade, according to a new Moody's analysis.
Why it matters: That means providers could face even higher costs in the coming years or, if positions go unfilled, some patients may go without the care they need.
Free COVID tests are over, for now. So are guidelines for infected people to isolate. Half of the country thinks the pandemic is finished.
But, in reality, COVID-19 is still with us. Though the official trappings of the crisis keep fading away and it's increasingly being treated like the flu, the virus remains an ever-present threat that's killing hundreds of Americans every week and consuming health care dollars and resources.
